Background:
Aldosterone dysregulation is becoming more widely acknowledged as a key factor in resistant hypertension. Baxdrostat, a highly selective aldosterone synthase inhibitor that shows a 100:1 preference for CYP11B2 over CYP11B1, has been tested in various randomized controlled trials involving different hyper...
Adir Alper, M. Lerner, A. Karthikeyan et al.· Circulation· 0 citations
Background:
The optimal strategy for long-term oral anticoagulation (OAC) after catheter ablation for atrial fibrillation (AF) remains uncertain. Although current guidelines recommend anticoagulation based on thromboembolic risk scores irrespective of rhythm status, this recommendation has not been validated by rand...
A. Karthikeyan, Maisha Maliha, Adir Alper et al.· Circulation· 0 citations
Once-weekly IcoSema delivers meaningful improvements in weight, blood pressure, and atherogenic lipids, all key modifiable drivers of ASCVD in adults with type 2 diabetes and suggests potential for enhanced ASCVD prevention and improved long-term adherence.
Adir Alper, Adina Fagin, A. Karthikeyan et al.· Cardiovascular Diabetology· 1 citation
SGLT-2 inhibitors provide a modest incremental benefit in lowering office systolic blood pressure for patients with uncontrolled or resistant hypertension on multidrug regimens with an overall acceptable safety profile.
Omer Mohammed, Sun Hyeok Kim, A. Karthikeyan et al.· High Blood Pressure & Cardio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.